Bernstein Maintains Outperform on Quantinuum, Raises Price Target to $95

Benzinga Newsdesk www.benzinga.com Positive 82.6%

Neg 0% Neu 0% Pos 82.6%

Bernstein analyst Mark Moerdler maintains Quantinuum (NASDAQ:QNT) with a Outperform and raises the price target from $94 to $95.